Technical Analysis for ABT - Abbott Laboratories

Grade Last Price % Change $ Change
grade B $40.76 -0.34% -0.14
ABT closed down 0.34 percent on Wednesday, January 18, 2017, on 78 percent of normal volume.

Earnings due: 2017-01-25

Track This Stock
Watchlist Portfolio
Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Flat
See historical ABT trend table...

Date Alert Name Type % Chg
Jan 12 200 DMA Support Bullish 0.10%
Jan 11 Slingshot Bullish Bullish Swing Setup -0.78%
Jan 11 200 DMA Support Bullish -0.78%
Jan 10 New Uptrend Bullish -1.28%
Jan 6 Expansion Pivot Buy Setup Bullish Swing Setup -0.05%
Jan 6 Stochastic Reached Overbought Other -0.05%
Jan 6 Upside 200 DMA Break Bullish -0.05%
Jan 5 50 DMA Support Bullish 2.67%
Jan 4 Bollinger Band Squeeze Range Contraction 3.56%
Jan 4 Crossed Above 50 DMA Bullish 3.56%

Older signals for ABT ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.

Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products worldwide. Its Established Pharmaceutical Products segment offers branded generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, pain, fever, inflammation, hypothyroidism, gynecological disorders, intrahepatic cholestasis or depressive symptoms, physiological rhythm of the colon, dyslipidemia, and hypertension, as well as provides anti-infective and influenza vaccines. The company’s Diagnostic Products segment provides diagnostic systems and tests, such as immunoassay and clinical chemistry systems; assays for screening and diagnosis for drugs of abuse, cancer, therapeutic drug monitoring, fertility, and physiological and infectious diseases; genomic-based tests; hematology systems and reagents; and diagnostic systems and tests for blood analysis, as well as instruments that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detects and measures infectious agents. Its Nutritional Products segment offers pediatric and adult nutritional products comprising various forms of prepared infant and follow-on formula. The company’s Vascular Products segment provides coronary, endovascular, vessel closure, and structural heart devices for the treatment of vascular disease. Abbott Laboratories also offers blood glucose monitoring meters, test strips, and data management software and accessories for people with diabetes; and medical devices for the eye, including cataract surgery, LASIK surgery, contact lens care products, and dry eye products. The company primarily serves retailers, wholesalers, hospitals, health care facilities, laboratories, physicians’ offices, and government agencies. The company was founded in 1888 and is headquartered in Abbott Park, Illinois.
Is ABT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 45.5
52 Week Low 35.34
Average Volume 9,184,027
200-Day Moving Average 40.48
50-Day Moving Average 39.28
20-Day Moving Average 39.52
10-Day Moving Average 40.63
Average True Range 0.7
ADX 26.88
+DI 29.8
-DI: 15.71
Chandelier Exit (Long, 3 ATRs) 39.52
Chandelier Exit (Short, 3 ATRs) 40.0
Upper Bollinger Band 41.91
Lower Bollinger Band 37.13
Percent B (%b) 0.76
Bandwidth 0.120951